O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.71B
AUM Growth
+$1.28B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
137
New
Increased
Reduced
Closed

Top Buys

1
+$249M
2
+$119M
3
+$107M
4
XLRN
Acceleron Pharma
XLRN
+$83.9M
5
CELG
Celgene Corp
CELG
+$76.1M

Top Sells

1
+$177M
2
+$71.8M
3
+$56.2M
4
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$56.1M
5
SPY icon
SPDR S&P 500 ETF Trust
SPY
+$50.4M

Sector Composition

1 Healthcare 84.81%
2 Financials 1.2%
3 Technology 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$375M 5.51%
4,992,600
+214,800
2
$306M 4.5%
1,095,100
+68,700
3
$297M 4.36%
3,514,200
+900,200
4
$290M 4.27%
5,465,000
+261,000
5
$287M 4.22%
2,515,300
-114,300
6
$249M 3.65%
+9,941,549
7
$206M 3.03%
4,069,000
-404,000
8
$203M 2.99%
738,800
+225,700
9
$199M 2.93%
6,247,000
+1,678,000
10
$199M 2.92%
3,760,900
+2,018,900
11
$183M 2.69%
4,214,500
-834,500
12
$179M 2.64%
3,758,000
+705,000
13
$177M 2.6%
1,641,510
+3,084
14
$173M 2.54%
4,218,605
+1,078,697
15
$171M 2.51%
1,534,200
-11,800
16
$127M 1.87%
2,669,256
-3,698,392
17
$120M 1.76%
713,000
+237,900
18
$119M 1.74%
+773,000
19
$118M 1.74%
1,734,934
-416,673
20
$113M 1.67%
7,697,000
+4,809,400
21
$109M 1.6%
3,744,862
-482,100
22
$107M 1.57%
2,888,500
+36,000
23
$107M 1.57%
4,237,600
+951,900
24
$102M 1.5%
724,000
+33,100
25
$99.5M 1.46%
1,414,100
-167,600
1
2 3 4 5